BAMS
ARIA

Bellevue Asset Management (Switzerland)’s Ariad Pharmaceuticals Inc ARIA Stock Holding History

Bellevue Asset Management (Switzerland)’s Portfolio ARIA Stock Details ARIA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		$3.09M Hold
495,000
– – 0.47% 66
2015
Q3 		$2.89M Hold
495,000
– – 0.47% 67
2015
Q2 		$4.09M Sell
495,000
-34,000
-6% -$301K 0.57% 59
2015
Q1 		$4.36M Buy
+529,000
New +$3.91M 0.61% 57

Other funds holding ARIA

PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return

Bellevue Asset Management (Switzerland)'s ARIA Position: Q4 2015 in Review

Bellevue Asset Management (Switzerland) held its Ariad Pharmaceuticals Inc (ARIA) position steady in Q4 2015 at 495,000 shares worth $3.09M. The position accounts for 0.47% of the portfolio, ranked #66.

Bellevue Asset Management (Switzerland) first reported a position in ARIA in Q1 2015 and has held it in 4 quarters since. The position peaked at $4.36M in Q1 2015. 172 funds tracked by Wall St. Rank hold ARIA as of Q4 2015.

  • Bellevue Asset Management (Switzerland) held 495,000 shares of Ariad Pharmaceuticals Inc worth $3.09M as of Q4 2015.
  • Bellevue Asset Management (Switzerland) left its Ariad Pharmaceuticals Inc share count unchanged in Q4 2015.
  • Ariad Pharmaceuticals Inc made up 0.47% of Bellevue Asset Management (Switzerland)'s portfolio in Q4 2015, its #66 holding.
  • Bellevue Asset Management (Switzerland) first reported a position in Ariad Pharmaceuticals Inc in Q1 2015 and has held it in 4 quarters since.
  • Bellevue Asset Management (Switzerland)'s Ariad Pharmaceuticals Inc position peaked at $4.36M in Q1 2015.
  • 172 funds tracked by Wall St. Rank held Ariad Pharmaceuticals Inc as of Q4 2015.

Based on Bellevue Asset Management (Switzerland)'s 13F filing for Q4 2015, filed 12 Feb 2016.